San Francisco - The evaluation and management of squamous cell carcinomas (SCCs) on the lower extremities mandates particular attention to the potential for those malignancies to arise at sites of other comorbidities, their increased risk for recurrence and metastasis, and problems with wound healing, according to Pamela K. Phillips, M.D.
